Cyproterone acetate
Cyproterone acetate
CLINICAL USE
Control of libido in severe hypersexuality and sexual deviation in adult maleManagement of patients with prostatic cancer (LHRH ‘flare’, palliative treatment)Hot flushes post orchidectomy
DOSE IN NORMAL RENAL FUNCTION
Control of hypersexuality: 50 mg twice dailyProstatic cancer: 200–300 mg/day in 2–3 divided dosesHot flushes: 50–150 mg daily in 1–3 divided doses
PHARMACOKINETICS
Molecular weight                           :416.9 %Protein binding                           :Approx 96 %Excreted unchanged in urine     : <1 Volume of distribution (L/kg)       :10–30 half-life – normal/ESRD (hrs)      :32.1–56.7/– DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function 10 to 20     : Dose as in normal renal function <10           : Dose as in normal renal function DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Unknown dialysability. Dose as in normal renal function HD                     :Unknown dialysability. Dose as in normal renal functionHDF/high flux   :Unknown dialysability. Dose as in normal renal functionCAV/VVHD      :Unknown dialysability. Dose as in normal renal function IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsNone known ADMINISTRATION
Reconstition
– Route
Oral Rate of Administration
–Comments
– OTHER INFORMATION
May cause drowsiness – increased CNS sensitivity in patients with renal impairmentCSM has advised that in view of the hepatotoxicity associated with long-term doses of 300 mg daily, the use of cyproterone acetate in prostatic cancer should be restricted to short courses, to cover testosterone ‘flare’ associated with gonadorelin analogues, treatment of hot flushes after orchidectomy or gonadorelin analogues, and for patients who have not responded to (or are intolerant of) other treatmentsDirect hepatic toxicity including jaundice, hepatitis and hepatic failure have been reported. Liver function tests should be performed before treatment and whenever symptoms suggestive of hepatotoxicity occur
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home